Author

Viral N Shah

Barbara Davis Center for Diabetes, University of Colorado - Cited by 5,743 - Type 1 diabetes and Bone metabolism

Biography

Viral N Shah is from Department of Endocrinology, Post Graduate Institute of Medical Education and Research, Chandigarh India He works as a professor ,Department of Endocrinology, Postgraduate Institute of Medical Education and Research, Chandigarh, India research intrest : Diabetic neuropathy; eNOS (endothelial nitric-oxide synthase); Gene polymorphism; gene polymorphisms; RAS inhibition therapy; Diabetic nephropathy
Title
Cited by
Year
Consensus recommendations for the use of automated insulin delivery technologies in clinical practice
M Phillip, R Nimri, RM Bergenstal, K Barnard-Kelly, T Danne, R Hovorka, ...Endocrine reviews 44 (2), 254-280, 2023202
47
2023
A glycemia risk index (GRI) of hypoglycemia and hyperglycemia for continuous glucose monitoring validated by clinician ratings
DC Klonoff, J Wang, D Rodbard, MA Kohn, C Li, D Liepmann, D Kerr, ...Journal of diabetes science and technology, 19322968221085273, 2022202
39
2022
Effect of divergent continuous glucose monitoring technologies on glycaemic control in type 1 diabetes mellitus: A systematic review and meta‐analysis of randomised controlled …
M Elbalshy, J Haszard, H Smith, S Kuroko, B Galland, N Oliver, V Shah, ...Diabetic Medicine 39 (8), e14854, 2022202
23
2022
Continuous glucose monitoring initiation within first year of type 1 diabetes diagnosis is associated with improved glycemic outcomes: 7-year follow-up study
A Champakanath, HK Akturk, GT Alonso, JK Snell-Bergeon, VN ShahDiabetes Care 45 (3), 750-753, 2022202
18
2022
Benefit of continuous glucose monitoring in reducing hypoglycemia is sustained through 12 months of use among older adults with type 1 diabetes
KM Miller, LG Kanapka, MR Rickels, AJ Ahmann, G Aleppo, L Ang, ...Diabetes technology & therapeutics 24 (6), 424-434, 2022202
17
2022
Efficacy and safety of tandem control IQ without user-initiated boluses in adults with uncontrolled type 1 diabetes
HK Akturk, J Snell-Bergeon, VN ShahDiabetes Technology & Therapeutics 24 (10), 779-783, 2022202
12
2022
How introduction of automated insulin delivery systems may influence psychosocial outcomes in adults with type 1 diabetes: Findings from the first investigation with the …
WH Polonsky, KK Hood, CJ Levy, SA MacLeish, IB Hirsch, SA Brown, ...Diabetes Research and Clinical Practice 190, 109998, 2022202
11
2022
Impact of different types of data loss on optimal continuous glucose monitoring sampling duration
HK Akturk, P Herrero, N Oliver, H Wise, E Eikermann, J Snell-Bergeon, ...Diabetes technology & therapeutics 24 (10), 49-53, 2022202
7
2022
Optimal sampling duration for continuous glucose monitoring for the estimation of Glycemia risk index
VN Shah, C Sakamoto, L PyleDiabetes Technology & Therapeutics 25 (2), 10-12, 2023202
4
2023
Differentiating diabetic ketoacidosis and hyperglycemic ketosis due to cannabis hyperemesis syndrome in adults with type 1 diabetes
HK Akturk, J Snell-Bergeon, GL Kinney, A Champakanath, A Monte, ...Diabetes Care 45 (), 481-483, 0
2
2022
Discordance between glucose management indicator and glycated hemoglobin in people without diabetes
VN Shah, T Vigers, L Pyle, P Calhoun, RM BergenstalDiabetes Technology & Therapeutics 5 (5), 34-38, 030
2
2023
759-P: Glycemic outcomes over 15 months with the Omnipod 5 automated insulin delivery system
AB Criego, AL Carlson, GP Forlenza, BW Bode, CJ Levy, DW Hansen, ...Diabetes 71 (Supplement_1), 0
2
2022
Hospital Diabetes Meeting 2022
Hospital Diabetes Meeting 0J Huang, AM Yeung, KT Nguyen, NY Xu, JC Preiser, RJ Rushakoff, ...Journal of diabetes science and technology 16 (5), 1309-1337, 0
2
2022
88-OR: Discordance between Glucose management indicator (Gmi) and A1C in well-controlled type 1 diabetes (T1D) and nondiabetic population
88-OR: Discordance between Glucose management indicator (Gmi) and AC in well-controlled type diabetes (TD) and nondiabetic populationV Shah, TB Vigers, L Pyle, S Dubose, P Calhoun, RM BergenstalDiabetes 7 (Supplement_), 2022202
1
2022
Symptomatic diabetic autonomic neuropathy in type 1 diabetes (T1D): Findings from the T1D exchange
Symptomatic diabetic autonomic neuropathy in type diabetes (TD): Findings from the TD exchangeK Mizokami-Stout, R Bailey, L Ang, G Aleppo, CJ Levy, MR Rickels, ...Journal of Diabetes and its Complications 36 (5), 0848, 2022202
1
2022
LONGITUDINAL RELATIONSHIP BETWEEN TIME IN RANGE AND HBA1C IN A REAL-WORLD CLINICAL PRACTICE SETTING
LONGITUDINAL RELATIONSHIP BETWEEN TIME IN RANGE AND HBAC IN A REAL-WORLD CLINICAL PRACTICE SETTINGR Mcqueen, M Perez-Nieves, G Alonso, R Juneja, L Fan, E Hankosky, ...Diabetes Technology & Therapeutics 24, A24-A25, 2022202
1
2022
New medications for the treatment of diabetes
SK Garg, E Rodriguez, VN Shah, IB HirschDiabetes Technology & Therapeutics 24 (S), S-90-S-208, 2022202
1
2022
Obesity and Diabetes
VN Shah, F Prattichizzo, A CerielloDiabetes Technology & Therapeutics 25 (S), S-27-S-226, 2023202
1
2023
Higher Prevalence of Hypoglycemia and Unsafe Driving Practices in Adults With Type 1 Diabetes
Higher Prevalence of Hypoglycemia and Unsafe Driving Practices in Adults With Type DiabetesAL Saunders, C Bodine, J Snell-Bergeon, GP Forlenza, VN ShahDiabetes Care 46 (4), e92-e93, 2023202
1
2023

Referred From: https://scholar.google.co.in/citations?user=XtGXbagAAAAJ&hl=en

Cited by
Citations 5743
h-index 40
i10-index 101
Recommended Journals
Open Access Journals